Wikipedia -WSS

Wikipedia

author：fashion 2025-09-02 08:25:37 - browse：8

Mathai Mammen crosses his arms and looks into the camera — coverage from STAT — FogPharma CEO Mathai Mammen Boston Globe Photo Import

Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have hit in recent years.

FogPharma, which is headquartered in Cambridge, Mass., is developing cancer treatments using corkscrew-shaped peptides called helicons that could possibly better breach cells.

As CEO Mathai Mammen sees it, very few exemplary medicines shuttle off of drug companies’ pipelines, wade through clinical trials, and end up in the hands of physicians and patients in a given year. Far more often, pharma and biotech companies are pushing out drugs that are incrementally better than what came before, extending cancer patients’ survival by a few more months, halting their tumor growth for a little while longer. But FogPharma could deliver something truly unique, Mammen said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： UCSF medical school apologizes for unethical prisoner experiments

Wikipedia

entertainment

WSS

UCSF medical school apologizes for unethical prisoner experiments

A controversial new treatment promises to make little people taller

How I helped Pfizer think through the ethics of Viagra

FDA approves Recor Medical high blood pressure device

Study: New antibiotic targets gonorrhea as well as last existing drug

CDC recommends RSV monoclonal antibody for infants

knowledge

Wikipedia

entertainment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Biotech incubator Curie.Bio graduates its first startup

23andMe had bad news about my health. I wish a person had delivered it

Abortion clinic in Cancun will cater to Americans

Cancer drug shortages should be causing more outrage

2 officers injured in shooting in Orlando, police say

United colonoscopy coverage change 'may cost lives,' doctors say

Biotech incubator Curie.Bio graduates its first startup

Moonlake's readout produced a cash windfall. Risks remain

10 million people disenrolled from Medicaid over past six months

knowledge

The cancer stories no one wants to hear

Alnylam reports growth in sales of rare disease treatments

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

The new shift in health care is toward less care

Pharma showers House GOP doctor with campaign cash

knowledge

Wikipedia

entertainment

focus